BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Nov 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-10-31

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-31	Common Stock	A	156	$68.442	Acquired	43100	Direct
2016-11-09	Common Stock	S	20000	$90.6103	Disposed	23100	Direct

Footnotes

F1: Represents shares acquired by the reporting person on October 31, 2016, pursuant to the issuer's Employee Stock Purchase Plan.

F2: The price in column 4 is the weighted average price. The price actually received ranged from $90.18 to $91.305. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.